GlassScriptPhysician profile
Chun H Auyeung
NPI 1073878476
$4,492.64
in general payments reported to CMS, 2019-2025
16 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,987 · 2020: $290 · 2021: $761 · 2022: $324 · 2023: $299 · 2024: $407 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,596.37 | 2019-2021 | |
| Alcon Vision LLC | $921.97 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $396.98 | 2022-2025 | Infuse, Miebo, Biotrue One Day |
| Coopervision INC. | $387.12 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $271.00 | 2019-2025 | |
| Kala Pharmaceuticals, INC. | $194.00 | 2021 | |
| Sun Pharmaceutical Industries INC. | $173.87 | 2019-2023 | Cequa |
| Novartis Pharmaceuticals Corporation | $114.87 | 2019-2021 | |
| Allergan, INC. | $110.76 | 2022 | |
| Eyevance Pharmaceuticals LLC | $108.04 | 2021 | |
| Dompe US, INC. | $95.40 | 2021-2025 | Oxervate |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $27.34 | 2025 | Xdemvy |
| Abbvie INC. | $27.27 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oasis Medical, INC. | $11.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chun Auyeung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.